Sai-Wen Tang

Senior Director of R&D @ Acepodia

About

Ten years of experience in cancer research. Experienced in developing immune cell therapy and utilizing CAR-T technology. Skilled to identify therapeutic targets by analyzing big data sets.

Country

United States

City

Alameda

Industry

Biotechnology

Skill

Western Blotting, Molecular Biology, Cancer Research, Cell Culture, Cell Biology, Biochemistry, PCR, Molecular Cloning, Confocal Microscopy, Microscopy, Protein Purification, Protein Expression, Immunohistochemistry, Luciferase Assay, autophagy, Molecular Virology, qPCR, ChIP-seq, Vector Cloning, ELISA

Experience

Senior Director of R&D

Acepodia

2024-4 - Present · 2 yrs 6 mos

Director of R&D

Acepodia

2018-6 - 2024-3 · 5 yrs 10 mos

California

Developing next-generation cell therapy utilizing CAR technology.

Research Scientist

Stanford University School of Medicine

2016-6 - 2018-6 · 2 yrs 1 mo

Development of immune cell therapy for Graft-Versus-Host Disease in allogeneic hematopoietic stem cell transplantation recipients.

Postdoc Fellow

The National Institutes of Health

2013-5 - 2016-3 · 2 yrs 11 mos

1. Analyzed cancer datasets NCI-60, CCLE and TCGA to identify regulatory mechanism for SLFN11. 2. Generated over-expressing cells by lentiviral infection to demonstrate the role of SLFN11 in sensitivity of cancer cells to chemotherapies. 3. Discovered drugs that sensitizing cancer cells to chemotherapies.

Postdoc Fellow at National Institute of Allergy and Infectious Diseases

The National Institutes of Health

2011-3 - 2013-4 · 2 yrs 2 mos

1. Investigated how human T cell leukemia virus type 1 (HTLV-1) escapes from host autophagic degradation by ex vivo infection system. 2. Identified the proteins interacting with autophagy receptor Tax1bp1 by immunoprecipitation and mass spectrometry analysis.

Postdoc Fellow

National Taiwan University

2009-8 - 2011-2 · 1 yr 7 mos

1. Constructed full-length cDNA libraries from tumor samples to identify cancer therapeutic targets and biomarkers by high-throughput DNA sequencing. 2. Demonstrated the role of nicotinamide N-methyltransferase (NNMT) in tumor metastasis. 3. Identified critical amino acids for methyltransferase activity of NNMT by X-ray crystallography.